Literature DB >> 10598714

Long-term survival of a patient with invasive cranial base rhinocerebral mucormycosis treated with combined endovascular, surgical, and medical therapies: case report.

C H Alleyne1, A G Vishteh, R F Spetzler, P W Detwiler.   

Abstract

OBJECTIVE: Rhinocerebral mucormycosis is a clinical syndrome resulting from an opportunistic infection caused by a fungus of the order Mucorales. The prognosis of rhinocerebral mucormycosis, once considered uniformly fatal, remains poor. Even with early diagnosis and aggressive surgical and medical therapy, the mortality rate is high. We present a patient with rhinocerebral mucormycosis involving the paranasal sinuses and cranial base who experienced long-term survival after multimodality treatment. Clinical characteristics of the disease are discussed, and the literature is reviewed. CLINICAL
PRESENTATION: A 24-year-old diabetic man presented with invasive rhinocerebral mucormycosis involving the paranasal sinuses, right middle fossa, and right cavernous sinus. INTERVENTION: The patient underwent endovascular sacrifice of the involved carotid artery and radical resection of the cranial base, including exenteration of the cavernous sinus. Reconstruction with a local muscle flap was performed. He continued to receive intravenous and intrathecal administration of antibiotics.
CONCLUSION: Long-term survival with invasive rhinocerebral mucormycosis is rare, but possible, with aggressive multimodality treatment, including carotid sacrifice for en bloc resection of the pathology, when indicated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10598714     DOI: 10.1097/00006123-199912000-00037

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  7 in total

1.  Rhinocerebral mucormycosis: pathways of spread.

Authors:  Seid Mousa Sadr Hosseini; Peyman Borghei
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-05-13       Impact factor: 2.503

Review 2.  Reconstruction in Rhino-Orbito-Cerebral Mucormycosis Survivors: A Systematic Review.

Authors:  Ved Prakash Rao Cheruvu; Manal M Khan
Journal:  Eplasty       Date:  2022-06-14

3.  Bilateral Cerebral Mucormycosis in an Immunocompetent Female.

Authors:  Remi T Okwechime; Nicholas Reyes; Darshan Trivedi; Ifeanyi O Iwuchukwu
Journal:  Ochsner J       Date:  2022

Review 4.  Current perspectives on ophthalmic mycoses.

Authors:  Philip A Thomas
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

5.  Isolated cerebral mucormycosis.

Authors:  Seong Rok Han; Chan Young Choi; Mee Joo; Choong Jin Whang
Journal:  J Korean Neurosurg Soc       Date:  2007-11-20

6.  Clinical features, diagnosis, and outcomes of rhino-orbito-cerebral mucormycosis- A retrospective analysis.

Authors:  A Abdollahi; T Shokohi; N Amirrajab; R Poormosa; A M Kasiri; S J Motahari; S M Ghoreyshi; S A Madani; M Nikkhah; M Ghasemi; L Vahedi Larijani; M Didehdar; Z Seifi; N Gholinejad; M Ilkit
Journal:  Curr Med Mycol       Date:  2016-12

Review 7.  Skull Base Osteomyelitis: A Comprehensive Imaging Review.

Authors:  P R Chapman; G Choudhary; A Singhal
Journal:  AJNR Am J Neuroradiol       Date:  2021-01-21       Impact factor: 3.825

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.